ArticleInternational journal of epidemiology2025
Impact of COVID-19 lockdown on outpatient care for non-communicable diseases in Nepal.
Article in International journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe implementation of restriction and mitigation measures to contain COVID-19 infection led to a significant disruption in the delivery of essential health services. However, the ramifications of the immediate COVID-19 containment policies on healthcare service utilization for major non-communicable diseases (NCDs)-related cases, particularly in low- and middle-income countries, remains unknown.
methodsWe used an interrupted time series study design, fitted with quasi-Poisson regression models, to assess the impacts of the nationwide lockdown on hospital visits for NCDs, namely cardiovascular disease (CVD), chronic respiratory disease (CRD), chronic kidney disease (CKD), cancer, and hypertension (HTN)-related cases, in Nepal. A total of 33 months of nationwide outpatient department visits data for NCD cases between July 2018 and April 2021, 20 months before and 13 months after the enforcement of the nationwide lockdown, were included in the final analysis.
resultsCompared with the expected level, there was an estimated 73% [relative risk (RR) 0.269, 95% confidence interval (CI): 0.089-0.808] decrease in outpatient department visits for CVD and a 64% (RR 0.361, 95% CI: 0.175-0.745) decrease for cancer. Although an immediate reduction in outpatient department visits was observed, the evidence was not conclusive to determine the true effect of the COVID-19 pandemic on outpatient department visits for CRD (RR 0.89, 95% CI: 0.651-1.228), HTN (RR 1.004, 95% CI: 0.64-1.575), and kidney disease (RR 0.589, 95% CI: 0.231-1.501).
conclusionWe estimated that the nationwide lockdown implemented in response to the COVID-19 pandemic affected hospital visits for patients with CVD and cancer. However, the available evidence was not conclusive enough to determine the impact of COVID-19 on outpatient department visits for the other NCDs analysed, namely HTN, CRD, and CKD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.